Methyl 2,4-dichloroquinazoline-5-carboxylate
- $541 - $1724
- Product name: Methyl 2,4-dichloroquinazoline-5-carboxylate
- CAS: 152536-24-8
- MF: C10H6Cl2N2O2
- MW: 257.07
- EINECS:
- MDL Number:MFCD13250069
- Synonyms:Methyl 2,4-dichloroquinazoline-5-carboxylate;5-Quinazolinecarboxylic acid, 2,4-dichloro-, methyl ester
5 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM210376
- Product descriptionMethyl2,4-dichloroquinazoline-5-carboxylate 95%
- Packaging1g
- Price$541
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM210376
- Product descriptionMethyl2,4-dichloroquinazoline-5-carboxylate 95%
- Packaging5g
- Price$1624
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11249374
- Product descriptionMethyl2,4-dichloroquinazoline-5-carboxylate 95+%
- Packaging1g
- Price$573
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11249374
- Product descriptionMethyl2,4-dichloroquinazoline-5-carboxylate 95+%
- Packaging5g
- Price$1724
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number123849
- Product descriptionMethyl2,4-dichloroquinazoline-5-carboxylate 95+%
- Packaging1g
- Price$1073
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM210376 | Methyl2,4-dichloroquinazoline-5-carboxylate 95% | 1g | $541 | 2021-12-16 | Buy |
Chemenu | CM210376 | Methyl2,4-dichloroquinazoline-5-carboxylate 95% | 5g | $1624 | 2021-12-16 | Buy |
Crysdot | CD11249374 | Methyl2,4-dichloroquinazoline-5-carboxylate 95+% | 1g | $573 | 2021-12-16 | Buy |
Crysdot | CD11249374 | Methyl2,4-dichloroquinazoline-5-carboxylate 95+% | 5g | $1724 | 2021-12-16 | Buy |
Matrix Scientific | 123849 | Methyl2,4-dichloroquinazoline-5-carboxylate 95+% | 1g | $1073 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|